190 related articles for article (PubMed ID: 8462213)
1. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
[TBL] [Abstract][Full Text] [Related]
2. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
Geatti O; Fig L; Shapiro B
Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
[TBL] [Abstract][Full Text] [Related]
3. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
[No Abstract] [Full Text] [Related]
4. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
Sialer G; Marincek B; Mengden T; Vetter W
Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
[TBL] [Abstract][Full Text] [Related]
5. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
[TBL] [Abstract][Full Text] [Related]
6. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
7. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
8. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
Barliev GB
Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
[TBL] [Abstract][Full Text] [Related]
9. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT
Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148
[TBL] [Abstract][Full Text] [Related]
10. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
[No Abstract] [Full Text] [Related]
11. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
[TBL] [Abstract][Full Text] [Related]
12. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
13. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
[TBL] [Abstract][Full Text] [Related]
14. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
Lindberg S; Ernest I; Fjälling M; Holmdahl C
Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
[TBL] [Abstract][Full Text] [Related]
15. Adrenal adenoma with bilateral adrenocortical nodular change in a patient with Cushing's syndrome.
Iino K; Sasano H; Nagura H; Watanabe F; Iwabuchi M; Ozawa M; Oki Y; Yoshimi T
Clin Endocrinol (Oxf); 1997 Sep; 47(3):371-5. PubMed ID: 9373462
[TBL] [Abstract][Full Text] [Related]
16. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
Reschini E; Baldini M; Cantalamessa L
Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
[TBL] [Abstract][Full Text] [Related]
17. Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls.
Pasieka JL; McLeod MK; Thompson NW; Gross MD; Schteingart DE
Surgery; 1992 Nov; 112(5):884-90. PubMed ID: 1440240
[TBL] [Abstract][Full Text] [Related]
18. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
Gross MD; Valk TW; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
[TBL] [Abstract][Full Text] [Related]
19. Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.
Gordon L; Mayfield RK; Levine JH; Lopes-Virella MF; Sagel J; Buse MG
J Nucl Med; 1980 Jan; 21(1):49-51. PubMed ID: 7356739
[TBL] [Abstract][Full Text] [Related]
20. [Role of adrenocortical scintigraphy in the exploration of incidentally discovered tumors].
Delemer B; Gibold C; Caron J; Liehn JC; Delisle MJ
Ann Endocrinol (Paris); 1992; 53(4):147-52. PubMed ID: 1339063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
